Corteva (NYSE:CTVA) Issues Earnings Results, Beats Expectations By $0.06 EPS

Corteva (NYSE:CTVA) issued its earnings results on Thursday. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06, Zacks reports. The business had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.24%. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.20 EPS. Corteva updated its FY 2026 guidance to 3.600-3.800 EPS.

Corteva Stock Performance

CTVA traded down $10.36 on Friday, reaching $78.98. 11,529,474 shares of the stock were exchanged, compared to its average volume of 3,285,966. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The company’s 50-day moving average price is $82.15 and its 200 day moving average price is $79.55. The firm has a market capitalization of $52.83 billion, a PE ratio of 52.31, a PEG ratio of 2.70 and a beta of 0.56. Corteva has a fifty-two week low of $60.53 and a fifty-two week high of $90.97.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is presently 42.35%.

Institutional Investors Weigh In On Corteva

A number of large investors have recently bought and sold shares of CTVA. JPL Wealth Management LLC purchased a new position in Corteva during the 3rd quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC acquired a new position in Corteva during the fourth quarter valued at $27,000. Bank of Jackson Hole Trust purchased a new position in shares of Corteva during the 4th quarter valued at about $28,000. Measured Wealth Private Client Group LLC acquired a new position in Corteva in the third quarter valued at approximately $33,000. Finally, Binnacle Investments Inc grew its stake in shares of Corteva by 54.7% during the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after purchasing an additional 181 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. BNP Paribas Exane increased their price target on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. CICC Research raised their target price on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Citigroup upped their price target on shares of Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Finally, The Goldman Sachs Group upped their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and an average target price of $90.19.

Corteva News Roundup

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Corteva reported second-quarter adjusted EPS of $2.30, exceeding the $2.24 analyst consensus and rising from $2.20 a year earlier. Seed pricing, productivity improvements, demand for newer genetics and traits, and growth in Crop Protection products supported margins. Reuters earnings report
• Positive Sentiment: The company raised its fiscal 2026 EPS outlook to $3.60-$3.80, reflecting strong first-half performance, operating improvements and growth platforms. Management also said it remains on track for the planned October 1 Vylor spin-off, a potential catalyst for improved business focus and valuation. Corteva first-half results and outlook
• Positive Sentiment: Analyst commentary remains broadly constructive: Corteva has outperformed the broader market and agriculture-focused ETFs, while brokerages maintain a consensus “Moderate Buy” rating. Momentum-focused analysis also highlights the company’s improving execution and fundamentals. Brokerage consensus rating
• Neutral Sentiment: Despite the earnings beat and higher guidance, one analysis argues that much of Corteva’s improved execution is already reflected in the stock, leaving limited upside unless earnings growth accelerates. Corteva valuation analysis
• Negative Sentiment: Second-quarter revenue was $6.38 billion, below the $6.60 billion consensus and down 1.2% year over year. The sales miss, together with competitive pricing pressure, appears to be the main reason the stock moved lower despite the profit beat and raised outlook. Corteva second-quarter earnings summary

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.